Genetic determinants of malignancy in a mouse model for oligodendroglioma

Cancer Research

Volumn 63, Issue 7, 2003, Pages 1589-1595

  Weiss, William A ^a   Burns, Michael J ^a   Hackett, Christopher ^a   Aldape, Ken ^b   Hill, John R ^a,e   Kuriyama, Hiroko ^a   Kuriyama, Nagato ^a   Milshteyn, Nadezhda ^a   Roberts, Tim ^c   Wendland, Michael F ^a   DePinho, Ron ^d   Israel, Mark A ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e NORRIS COTTON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; PROTEIN S100B;

ALLELE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CHROMOSOME 1P; CHROMOSOME 4; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; OLIGODENDROGLIOMA; ONCOGENE; ONCOGENE V ERB B; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BRAIN NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, MAMMALIAN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE MODELS, ANIMAL; GENES, ERBB-1; GENES, P53; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MUTATION; NERVE GROWTH FACTORS; OLIGODENDROGLIOMA; ONCOGENE PROTEINS V-ERBB; PROMOTER REGIONS (GENETICS); RECEPTOR, EPIDERMAL GROWTH FACTOR; S100 PROTEINS; TUMOR CELLS, CULTURED;

EID: 0037382205     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bleyer, W. A. Epidemiologic impact of children with brain tumors. Childs Nerv. Syst., 15: 758-763, 1999.
2. DeAngelis, L. M. Brain tumors. N. Engl. J. Med., 344: 114-123, 2001.
3. Schwechheimer, K. G. P., and Berlet, H. H. Expression of oligodendroglia and Schwann cell markers in human nervous system tumors. An immunomorphological study and western blot analysis. Acta Neuropathol. (Berl.), 82: 283-291, 1992.
4. Lu, Q. R., Park, J. K., Noll, E., Chan, J. A., Alberta, J., Yuk, D., Alzamora, M. G., Louis, D. N., Stiles, C. D., Rowitch, D. H., and Black, P. M. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc. Natl. Acad. Sci. USA, 98: 10851-10856, 2001.
5. Marie, Y., Sanson, M., Mokhtari, K., Leuraud, P., Kujas, M., Delattre, J. Y., Poirier, J., Zalc, B., and Hoang-Xuan, K. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet, 358: 298-300, 2001.
6. Hoang-Xuan, K., Aguirre-Cruz, L., Mokhtari, K., Marie, Y., and Sanson, M. OLIG-1 and 2 gene expression and oligodendroglial tumours. Neuropathol. Appl. Neurobiol., 28: 89-94, 2002.
7. Reifenberger, J., Reifenberger, G., Ichimura, K., Schmidt, E. E., Wechsler, W., and Collins, V. P. Epidermal growth factor receptor expression in oligodendroglial tumors. Am. J. Pathol., 149: 29-35, 1996.
8. Ohgaki, H., Eibl, R. H., Wiestler, O. D., Yasargil, M. G., Newcomb, E. W., and Kleihues, P. p53 mutations in nonastrocytic human brain tumors. Cancer Res., 51: 6202-6205, 1991.
9. Duerr, E. M., Rollbrocker, B., Hayashi, Y., Peters, N., Meyer-Puttlitz, B., Louis, D. N., Schramm, J., Wiestler, O. D., Parsons, R., Eng, C., and Deimling, A. PTEN mutations in gliomas and glioneuronal tumors. Oncogene, 16: 2259-2264, 1998.
10. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (Lond.), 313: 144-147, 1985.
11. von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Wiestler, O. D., and Seizinger, B. R. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res., 52: 4277-4279, 1992.
12. Reifenberger, J., Reifenberger, G., Liu, L., James, C. D., Wechsler, W., and Collins, V. P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am. J. Pathol., 145: 1175-1190, 1994.
13. Ino, Y., Betensky, R. A., Zlatescu, M. C., Sasaki, H., Macdonald, D. R., Stemmer-Rachamimov, A. O., Ramsay, D. A., Cairncross, J. G., and Louis, D. N. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res., 7: 839-845, 2001.
14. Buckner, J. C., Gesme, D., Jr., O'Fallon, J. R., Hammack, J. E., Stafford, S., Brown, P. D., Hawkins, R., Scheithauer, B. W., Erickson, B. J., Levitt, R., Shaw, E. G., and Jenkins, R. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J. Clin. Oncol., 21: 251-255, 2003.
15. Bauman, G. S., Ino, Y., Ueki, K., Zlatescu, M. C., Fisher, B. J., Macdonald, D. R., Stitt, L., Louis, D. N., and Cairncross, J. G. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int. J. Radiat. Oncol. Biol. Phys., 48: 825-830, 2000.
16. Cairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., Ramsay, D. A., and Louis, D. N. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. (Bethesda), 90: 1473-1479, 1998.
17. Ludwin, S. K., Kosek, J. C., and Eng, L. F. The topographical distribution of S-100 and GFA proteins in the adult rat brain: an immunohistochemical study using horseradish peroxidase-labelled antibodies. J. Comp. Neurol., 165: 197-207, 1976.
18. Wilkinson, M., Hume, R., Strange, R., and Bell, J. E. Glial and neuronal differentiation in the human fetal brain 9-23 weeks of gestation. Neuropathol. Appl. Neurobiol., 16: 193-204, 1990.
19. Rickmann, M., and Wolff, J. R. S100 immunoreactivity in a subpopulation of oligodendrocytes and Ranvier's nodes of adult rat brain. Neurosci. Lett., 186: 13-16, 1995.
20. Marone, M., Quinones-Jenab, V., Meiners, S., Nowakowski, R. S., Ho, S. Y., and Geller, H. M. An immortalized mouse neuroepithelial cell line with neuronal and glial phenotypes. Dev. Neurosci., 17: 311-323, 1995.
21. Zhou, F. C., and Chiang, Y. H. Long-term nonpassaged EGF-responsive neural precursor cells are stem cells. Wound Repair Regen., 6: 337-348, 1998.
22. Jiang, H., Shah, S., and Hilt, D. C. Organization, sequence, and expression of the murine S100 beta gene. Transcriptional regulation by cell type-specific cis-acting regulatory elements. J. Biol. Chem., 268: 20502-20511, 1993.
23. Hogan, B. R., Beddington, F., Costantini, F., and Lacy, E. (eds.). Manipulation of the Mouse Embryo: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1994.
24. Schatzman, R. C., Evan, G. I., Privalsky, M. L., and Bishop, J. M. Orientation of the v-erb-B gene product in the plasma membrane. Mol. Cell. Biol., 6: 1329-1333, 1986.
25. Weiss, W. A., Aldape, K., and Bishop, J. M. Targeted expression of NMYC causes neuroblastoma in transgenic mice. Eur. Mol. Biol. Org. 3., 16: 2985-2995, 1997.
26. Kleihues, P., Louis, D. N., Scheithauer, B. W., Rorke, L. B., Reifenberger, G., Burger, P. C., and Cavenee, W. K. The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol., 61: 215-225; discussion 226-219, 2002.
27. Min, K. W., and Scheithauer, B. W. Oligodendroglioma: the ultrastructural spectrum. Ultrastruct. Pathol., 18: 47-60, 1994.
28. Hasso, A. M., Korlman, K. E., and Bradley, W. G. Supratentorial neoplasms. In: D. Stark and W. G. Bradley (eds.), Magnetic Resonance Imaging, pp. 770-818. St. Louis: Mosby, 1992.
29. Sage, M. R., and Wilson, A. J. The blood-brain barrier: an important concept in neuroimaging. AJNR Am. J. Neuroradiol., 15: 601-622, 1994.
30. Miettinen, H., Kononen, J., Sallinen, P., Alho, H., Helen, P., Helin, H., Kalimo, H., Paljarvi, L., Isola, J., and Haapasalo, H. CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas. J. Neurooncol., 41: 205-211, 1999.
31. Sherr, C. J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell. Biol., 2: 731-737, 2001.
32. Smith, J. S., Alderete, B., Minn, Y., Borell, T. J., Perry, A., Mohapatra, G., Hosek, S. M., Kimmel, D., O'Fallon, J., Yates, A., Feuerstein, B. G., Burger, P. C., Seheithauer, B. W., and Jenkins, R. B. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene, 18: 4144-4152, 1999.
33. Smith, J. S., Perry, A., Borell, T. J., Lee, H. K., O'Fallon, J., Hosek, S. M., Kimmel, D., Yates, A., Burger, P. C., Scheithauer, B. W., and Jenkins, R. B. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J. Clin. Oncol., 18: 636-645, 2000.
34. Ino, Y., Zlatescu, M. C., Sasaki, H., Macdonald, D. R., Stemmer-Rachamimov, A. O., Jhung, S., Ramsay, D. A., von Deimling, A., Louis, D. N., and Cairncross, J. G. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J. Neurosurg. 92: 983-990, 2000.
35. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
36. Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., and Bedi, A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev., 14: 34-44, 2000.
37. Zhang, L., Yu, D., Hu, M., Xiong, S., Lang, A., Ellis, L. M., and Pollock, R. E. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res, 60: 3655-3661, 2000.
38. Reeves, R. H., Yao, J., Crowley, M. R., Buck, S., Zhang, X., Yarowsky, P., Gearhart, J. D., and Hilt, D. C. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc. Natl. Acad. Sci. USA, 91: 5359-5363, 1994.
39. Dai, C., Celestino, J. C., Okada, Y., Louis, D. N., Fuller, G. N., and Holland, E. C. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev., 15: 1913-1925, 2001.
40. Doetsch, F., Caille, I., Lim, D. A., Garcia-Verdugo, J. M., and Alvarez-Buylla, A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell, 97: 703-716, 1999.
41. Schrock, E., Blume, C., Meffert, M. C., du Manoir, S., Bersch, W., Kiessling, M., Lozanowa, T., Thiel, G., Witkowski, R., Ried, T., and Cremer, T. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomie hybridization. Genes Chromosomes Cancer, 15: 199-205, 1996.
42. Weber., R. G., Sabel, M., Reifenberger, J., Sommer, C., Oberstrass, J., Reifenberger, G., Kiessling, M., and Cremer, T. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene, 13: 983-994, 1996.